Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F6QT1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,721
Award facts
- Contract value 100% obligated
- $26,721.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,721.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract type. The award was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and reflects a non-competitive set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same jurisdiction. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
The delivery order supports the Defense Health Agency's pharmaceutical supply requirements as part of the DLA's comprehensive medical supply chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, maintains an extensive portfolio of federal medical contracts covering a broad range of brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Eliquis, an anticoagulant medication, exemplifies the company's role in supplying essential pharmaceuticals to support military and veteran healthcare systems. The non-set-aside competitive award reflects AmerisourceBergen's demonstrated capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DR26F6QT1?
SPE2DR26F6QT1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F6QT1 worth?
The government has obligated $26,721 on SPE2DR26F6QT1.
Is contract SPE2DR26F6QT1 an order under another contract?
Yes. SPE2DR26F6QT1 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6QT1 competed?
The extent of competition for SPE2DR26F6QT1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award